MAPT and Alzheimer disease: Alzheimer's disease (AD) is characterized by a progressive cognitive decline linked to both extracellular deposits of aggregated amyloid beta (Aβ) peptides into plaques and the intraneuronal aggregation of hyperphosphorylated tau proteins.1